Evidence map›Paper›PMID 41290357›Full record

ArticleJournal of applied clinical medical physics2025

Multi-institutional study on the commissioning and clinical implementation of the TrueBeam enhanced leaf model in the Eclipse treatment planning system.

Ryohei Miyasaka, Ryuta Hirai, Yuhi Suda, Ryohei Yamauchi, Norifumi Mizuno, Yuya Suzuki, Mitsunobu Igari, Tomohiro Ohta, Hiroki Nakayama, Yu Arai and 6 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ryohei MiyasakaDivision of Radiation Oncology, Chiba Cancer Center, Chiba, Chiba, Japan.
Ryuta HiraiDepartment of Radiation Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Yuhi SudaDepartment of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Ryohei YamauchiDepartment of Radiation Oncology, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7719-143X
Norifumi MizunoDepartment of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.ORCID https://orcid.org/0000-0002-2991-3423
Yuya SuzukiDepartment of Radiological Technology, Tokyo Saiseikai Central Hospital, Minato-ku, Tokyo, Japan.
Mitsunobu IgariDepartment of Radiation Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Tomohiro OhtaDepartment of Radiation Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Hiroki NakayamaRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Yu AraiDepartment of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Kaito SakaiDepartment of Radiology, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan.ORCID https://orcid.org/0009-0007-6947-2312
Kazushi HatakeyamaDepartment of Radiation Control, Radiological Oncology, St. Marianna University Hospital, Kawasaki, Kanagawa, Japan.
Hisayuki MiyashitaDepartment of Radiation Control, Radiological Oncology, St. Marianna University Hospital, Kawasaki, Kanagawa, Japan.
Masahiko KurookaDepartment of Radiation Therapy, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, Japan.
Toru KawachiDivision of Radiation Oncology, Chiba Cancer Center, Chiba, Chiba, Japan.
Ryusuke HaraDivision of Radiation Oncology, Chiba Cancer Center, Chiba, Chiba, Japan.

Funding

Varian Medical Systems
6 · The paper itself

Abstract

purposeRecently, the Enhanced Leaf Modeling (ELM) was developed to improve the multileaf collimator (MLC) model in the Eclipse treatment planning system (TPS). This multi-institutional study evaluated the dose calculation accuracy and clinical feasibility of the ELM for TrueBeam linear accelerators (linacs) equipped with Millennium 120 and High-Definition 120 MLCs. In addition, to facilitate broader clinical adoption, the feasibility of using machine-averaged ELMs (ELM

methodsTwelve TrueBeam linacs from nine institutions were included. Machine-specific ELM (ELM

resultsFor the ELM

conclusionsThe ELM

Indexed as

Head and Neck NeoplasmsParticle AcceleratorsPhantoms, ImagingProstatic NeoplasmsRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedSpinal NeoplasmsAlgorithmsHumansMaleOrgans at RiskRadiotherapy Dosagedose verificationELMMLCmulti‐institutional studyVMAT

Identifiers

PMID41290357
PMCPMC12646809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.